July 22, 2024

Gaining weight on antiretrovirals - Trip Gulick, MD/ Michael Saag, MD

4 minutes

A 36-year-old obese white man (BMI 34) recently diagnosed with HIV (CD4 560, HIV RNA 52,000) is recommended to start antiretroviral therapy but is concerned about weight gain.

Which is true of antiretroviral-induced weight gain?

A. Raltegravir is associated with more weight gain than dolutegravir

B. Elvitegravir is associated with more weight gain than bictegravir

C. Tenofovir AF is associated with more weight gain than tenofovir DF

D. White men have the highest rates of weight gain on ART

...more

View all episodes

By John Bennett, MD / Henry Masur, MD

22 ratings

July 22, 2024

Gaining weight on antiretrovirals - Trip Gulick, MD/ Michael Saag, MD

4 minutes

A 36-year-old obese white man (BMI 34) recently diagnosed with HIV (CD4 560, HIV RNA 52,000) is recommended to start antiretroviral therapy but is concerned about weight gain.

Which is true of antiretroviral-induced weight gain?

A. Raltegravir is associated with more weight gain than dolutegravir

B. Elvitegravir is associated with more weight gain than bictegravir

C. Tenofovir AF is associated with more weight gain than tenofovir DF

D. White men have the highest rates of weight gain on ART

...more

Share Gaining weight on antiretrovirals - Trip Gulick, MD/ Michael Saag, MD

Sign up to save your podcasts

Gaining weight on antiretrovirals - Trip Gulick, MD/ Michael Saag, MD

Gaining weight on antiretrovirals - Trip Gulick, MD/ Michael Saag, MD